WOMAC pain score

Biomarker

1 paper1 finding

Interventions

1

Semaglutide

downin humans1

1 study
  1. Semaglutide decreases WOMAC pain score in humans (-41.7 points vs -27.5 points placebo).

    ReviewSTEP 9 trial2.4 mg68 weeksn = 407

    Glucagon-like Peptide-1 Receptor Agonists and Chronic Pain: Preclinical Antinociceptive Mechanisms, Indirect Metabolic-Functional Effects, and Clinical Considerations-A Narrative Review

    Journal of clinical medicine29 Jul 2026

More on Semaglutide

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 1Oct 2026: 02 in 12 months
The New England Journal of Medicine

Retatrutide reduces weight and pain in adults with obesity

Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.

Randomised trial in 2,339 peopleRetatrutide